510(k) K231422
K231422 is an FDA 510(k) premarket notification submitted by Limaca Medical, Ltd. for the device "Precision GI". The FDA issued a decision of Substantially Equivalent on August 28, 2023. The device falls under product code FCG (Biopsy Needle), a Class II device regulated under 21 CFR 876.1075.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 28, 2023
- Date Received
- May 17, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Biopsy Needle
- Device Class
- Class II
- Regulation Number
- 876.1075
- Review Panel
- GU
- Submission Type